Hepatocellular Carcinoma Prediction Models in Chronic Hepatitis B: A Systematic Review of 14 Models and External Validation - Wu, Shanshan; Zeng, Na; Sun, Feng; Zhou, Jialing; Wu, Xiaoning; Sun, Yameng; Wang, Bingqiong; Zhan, Siyan; Kong, Yuanyuan; Jia, Jidong; You, Hong; Yang, Hwai-I (Clinical gastroenterology and hepatology, 2021)
Keywords: Antiviral Agents - therapeutic use; Carcinoma, Hepatocellular - diagnosis; Carcinoma, Hepatocellular - drug therapy; Chronic Hepatitis B; Cohort Studies; External Validation; Gastroenterology and Hepatology; Hepatitis B, Chronic - complications; Hepatitis B, Chronic - drug therapy; Hepatocellular Carcinoma; Humans; Liver Neoplasms - diagnosis; Liver Neoplasms - drug therapy; Meta-Analysis; Prediction Model; Risk Factors; Chronic Hepatitis B; Meta-Analysis; Prediction Model; BFH; E; CI; HBeAg; LSM; ALT; AUROC; HCC; AFP; O; BS; External Validation; ALB; PLT; CHB; HBV; Hepatocellular Carcinoma; hepatitis B virus; alanine aminotransferase; hepatitis B e antigen; observed; area under the receiver-operating characteristic curve; α-fetoprotein; Beijing Friendship Hospital; liver stiffness measurement; expected; Brier score; albumin; platelet; confidence interval